1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Asthma Copd: new trials by email Literature Review of Asthma Copd trials Research Report on Asthma Copd
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg - Asthma Copd | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 472 | 2023-04-19 | 2026-10-26 |
| The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) Conventional rehabilition treatment(e.g leaflet) educated by hospital, Digital treatment based on Respiratory Rehabilitation Software - Respiratory System Disease, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Lifesemantics Corp. | 100 | 2022-01-13 | 2022-03-29 |
Lung Diseases (1) · Lung Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1) · Respiratory Tract Diseases (1)
Chronic Disease (1) · Disease Attributes (1) · Lung Diseases, Obstructive (1) · Neoplasms (1) · Neoplasms by Site (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Eurofarma Laboratorios S.A. (1) · Lifesemantics Corp. (1)
Brazil (1) · South Korea (1)